EPIC Act of 2025

# EPIC Act of 2025 Summary **What the Bill Would Do:** The EPIC Act would delay when certain prescription drugs become eligible for Medicare price negotiations. Currently, the government can negotiate prices for drugs that have been on the market for at least 7 years (or 11 years for biological drugs). This bill would extend that waiting period to 11 years for all drug products, meaning fewer drugs would be available for negotiation in the near term. **Who It Affects:** The bill primarily affects Medicare beneficiaries (seniors and disabled individuals), who could see continued high drug prices longer for newly approved medications.

It also impacts pharmaceutical companies, which would have extended periods of higher pricing before government negotiation kicks in. The change would delay cost-saving negotiations starting in 2028. **Current Status:** The bill was introduced by Senator Thomas Tillis (R-NC) and is currently in committee, meaning it has not yet been voted on by the full Senate. The bill represents an effort to modify the Medicare Drug Price Negotiation Program that was established in recent legislation.